2026 ICD-10-CM Diagnosis Code D75.89Other specified diseases of blood and blood-forming organs

ICD-10-CM Codes›D50–D89›D70-D77›D75

ICD-10-CM D75.89
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

D75.89 is a billable ICD-10-CM diagnosis code for other specified diseases of blood and blood-forming organs. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 814 through 816. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other specified and unspecified hematologic conditions.

Code Identity

ICD-10-CM Code
D75.89
Billable Status
Yes — Valid for Submission
Code Describes
Other specified diseases of blood and blood-forming organs
Short Description
Other specified diseases of blood and blood-forming organs
Same as the full description in the CMS dataset.
Parent Code
D75.8
Other specified diseases of blood and blood-forming organs

Code Classification

ChapterD50–D89Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
SectionD70-D77Other disorders of blood and blood-forming organs
CategoryD75Other and unspecified diseases of blood and blood-forming organs
This CodeD75.89Other specified diseases of blood and blood-forming organs

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Abnormal megakaryocyte production
  • Acquired pancytopenia
  • Acute radiation syndrome
  • Acute vomiting
  • AL amyloidosis
  • Alcoholic macrocytosis
  • Alcohol-related macrocytosis
  • Anemia caused by physical agent
  • Anemia due to radiation
  • Blood group deletion syndrome
  • Blood viscosity above reference range
  • Blood viscosity level - finding
  • Bone marrow depression
  • Bone marrow hyperplasia
  • Bone marrow myeloid cells - finding
  • Complete trisomy 21 syndrome
  • Congenital anomaly of the hematopoietic system
  • Cytopenia
  • Deficiency of hexokinase
  • Disorder of bone marrow caused by ionizing radiation
  • Dysplasia of megakaryocyte cell
  • Edema of bone marrow
  • Eosinophilic hyperplasia of bone marrow
  • Erythroid dysplasia of bone marrow
  • Erythroid hyperplasia of bone marrow
  • Extramedullary hematopoiesis
  • Finding of bone marrow erythropoiesis
  • Granulocytic hyperplasia of bone marrow
  • Hematopoietic maturation arrest
  • Hematopoietic subsyndrome of acute radiation syndrome
  • Hemolytic disorder
  • Hyperviscosity
  • Hyperviscosity syndrome
  • Ineffective hematopoiesis
  • Light chain disease
  • Macrocytosis
  • Macrocytosis - no anemia
  • Megakaryocytic hyperplasia of bone marrow
  • Mild bone marrow hyperplasia
  • Mild cytopenia
  • Moderate bone marrow hyperplasia
  • Moderate cytopenia
  • Myeloid hyperplasia of bone marrow
  • Myelosuppression
  • Myelosuppression due to chemotherapy
  • Neutrophilic hyperplasia of bone marrow
  • Non-anemic red cell disorder
  • Non-malignant lymphocyte AND/OR plasma cell disorder
  • Osteosarcoma, limb anomalies, erythroid macrocytosis syndrome
  • Plasma cell hyperplasia of bone marrow
  • Polyclonal hyperviscosity syndrome
  • Primary cytopenia
  • Primary systemic amyloidosis associated with occult plasma cell dyscrasia
  • Pseudolymphoma
  • Radiation sickness
  • Recurrent bone marrow hyperplasia
  • Red blood cell size - finding
  • Reticulocyte count outside reference range
  • Reticulocytopenia
  • Severe bone marrow hyperplasia
  • Severe cytopenia
  • Sideropenic anemia with reticuloendothelial siderosis
  • T-cell mediated cytopenia
  • Toxic cytopenia
  • Transient abnormal myelopoiesis
  • Transient abnormal myelopoiesis co-occurrent with Down syndrome
  • Transitory cytopenia
  • Triose phosphate isomerase deficiency

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Depression(acute) (mental)
      • bone marrow
    • Dysfunction
      • hemoglobin
    • Erythrophagocytosis
    • Hyperplasia, hyperplastic
      • bone
        • marrow
    • Hyperplasia, hyperplastic
      • erythroid
    • Hyperplasia, hyperplastic
      • reticulo-endothelial (cell)
    • Macrocytosis
    • Marrow(bone)
      • poor function
    • Myelosclerosis
    • Osteomyelosclerosis
    • Pancytolysis

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR BLD010
Other specified and unspecified hematologic conditions
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Acute Radiation Syndrome

    a condition caused by a brief whole body exposure to more than one sievert dose equivalent of radiation. acute radiation syndrome is initially characterized by anorexia; nausea; vomiting; but can progress to hematological, gastrointestinal, neurological, pulmonary, and other major organ dysfunction.

  • Pseudolymphoma

    a group of disorders having a benign course but exhibiting clinical and histological features suggestive of malignant lymphoma. pseudolymphoma is characterized by a benign infiltration of lymphoid cells or histiocytes which microscopically resembles a malignant lymphoma. (from dorland, 28th ed & stedman, 26th ed)

  • Cytopenia

    a deficiency in or reduction of the number of blood cells.

  • Reticulocytopenia

    abnormally low level of immature red blood cells in the blood.

  • Cutaneous Pseudolymphoma|Lymphadenosis Benigna Cutis|Lymphocytoma Cutis|Pseudolymphoma of Spiegler

    a pseudolymphoma of the skin.

  • Endometrial Lymphoma-Like Lesion|Endometrial Pseudolymphoma

    dense diffuse and superficial infiltration of the endometrium by lymphoid cells. it is typically seen in association with chronic endometritis.

  • Pseudolymphoma

    a neoplastic process that resembles a malignant lymphoma, but has a benign course.

  • Ineffective Hematopoiesis

    a dysfunction in the production of blood cells, resulting in decreased numbers of mature, functioning blood cells of all lines in circulation.

  • Cutaneous Pseudolymphoma|Lymphadenosis Benigna Cutis|Lymphocytoma Cutis|Pseudolymphoma of Spiegler

    a dense cutaneous non-neoplastic lymphocytic proliferation composed of b-or t-cells with histological and clinical characteristics resembling cutaneous lymphoma.

Patient EducationClinical

Blood Disorders

Your blood is living tissue made up of liquid and solids. The liquid part, called plasma, is made of water, salts and protein. Over half of your blood is plasma. The solid part of your blood contains red blood cells, white blood cells and platelets.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert D75.89 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
289.89 Blood diseases NEC
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About D75.89Overview

Is D75.89 (Other specified diseases of blood and blood-forming organs) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report other specified diseases of blood and blood-forming organs on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does D75.89 group to?

When other specified diseases of blood and blood-forming organs is the principal diagnosis on an inpatient stay, it groups to MS-DRG 814, 815, 816, with relative weights from 0.6320 to 2.1267 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of D75.89?

Under the General Equivalence Mappings, other specified diseases of blood and blood-forming organs converts to ICD-9-CM 289.89 (blood diseases NEC). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.